EPAS1 and nonpapillary renal cell carcinoma: Furthermore, although VHL mutations are found in the vast majority of ccRCCs (~90%) and in the hypoxic subtype of PPGL, HIF2α mutations (EPAS1) are rare overall, not seen in ccRCC, and typically only occur as somatic mutations (not germline) in a subset of PPGLs (44).